The company deploys the next phase of work
Release time:
2020-07-22
Efforts to Recover the Losses Caused by the Epidemic
Company Deploys the Next Phase of Work
News 4# October 16 , 17 , the company successively held work analysis meetings for pharmaceutical sector, cement sector and directly affiliated enterprises to summarize and take stock of the gains and losses of the work in the first quarter, requirements for this year's follow-up work, especially in the second quarter. At the
analysis meeting, the heads of the enterprises reported the work situation in the first quarter, focusing on the analysis of the existing problems, and put forward solutions and improvement plans. In the first quarter of this year, due to the outbreak of the new coronavirus pneumonia epidemic, the epidemic situation and prevention and control measures vary from place to place, the Spring Festival holiday was extended, the flow of people and logistics was blocked, the market was stagnant for a long time, and all business sectors of the company were affected to varying degrees. Since the resumption of work, the subordinate enterprises in earnest to do a good job in the prevention and control of the epidemic at the same time, to overcome many difficulties in efforts to resume work and production. In particular, the Daye Peak Cement Company, which is located in the central area of the epidemic, with the help and coordination of local government departments at all levels, organized manpower, scientifically arranged processes, and carried out a comprehensive overhaul of production equipment. Guizhou Peak, Peak Pharmaceutical Internationalization, Anhui New North Card - Zhongwang Phase II and other projects under construction have also overcome many difficulties and the project construction has returned to normal progress. Since the outbreak of the epidemic, there has been no case of infection in the whole group company, the state of mind of the employees is stable, and all production and operation work has been on the right track. At the
work analysis meeting, chairman Jiang Xiaomeng, general manager Yu Jianhong and other group company leaders commented on the work of each business sector one by one based on the economic and technical data of each enterprise in the first quarter, pointed out the highlights of the work, analyzed the problems and deficiencies, and put forward guidance and work requirements on how to further improve the work quality and minimize the losses caused by the epidemic in the second three quarters of this year.
Spike Pharmaceuticals: Catch Products, Reduce Costs, Strong Marketing
The meeting pointed out that the pharmaceutical industry has strong policy relevance, high technical requirements, and subsequent changes due to the epidemic are more complex. In view of the current actual situation of Jianfeng Pharmaceutical and the changing trend of the industry after the epidemic, it is necessary to concentrate superior resources according to the company's established development strategic objectives, and solidly cultivate the enterprise's own competitive advantages; further strengthen the internal integration of the enterprise, strengthen and build a streamlined and capable workforce; continue to strengthen process reengineering, and further straighten out every link from procurement, production to organizational structure establishment; go all out to break through the "intestinal obstruction" phenomenon in the whole process of product research and development, verification, production and listing; further optimize the sales team, strengthen the planning before the launch of new products, and strive for new breakthroughs in sales; further strengthen scientific and technological innovation, speed up the construction and optimization of R & D platform; do a good job in safety and environmental protection management with a "zero tolerance" attitude, improve the safety and environmental protection management system and process, and improve the staff awareness and related skills level. The
meeting pointed out that the impact of the epidemic, the import of pharmaceutical raw materials and intermediates has been blocked, objectively bringing new development opportunities to relevant domestic enterprises. North Carolina Company and its subordinate enterprises should pay attention to the management of production, quality and safety, and strive for more market opportunities in time.
Cement Plate: Strengthen Management, Reduce Costs, Set Advantages, and Seek Development
Among the company's various industrial plates, the cement plate is most obviously affected by business conditions. With the improvement of the epidemic prevention and control situation, the production and sales of two cement enterprises, Daye Peak and Yunnan Peak, have gradually returned to normal levels, and the construction of Guizhou Peak is also progressing steadily. The meeting pointed out that the current technological progress in the cement industry is very fast, and the future development of enterprises is facing severe challenges. The peak cement sector must arm itself from the control of management, technology and resources, and strive to establish advantages in market competition. We should further do a good job in fine management, standardized management and on-site rectification. In view of the fact that the current epidemic has not been completely lifted and the market is in a recovery period, we will impose management, maintenance and further expansion. After Daye Peak carries out system transformation, it is necessary to do a good job in equipment operation management to ensure that the equipment reaches the predetermined standard as soon as possible and improve the effective operation rate; at the same time, it is necessary to strengthen communication with local government departments at all levels to strive for further development. Yunnan Jianfeng should make great efforts to do a good job in mine renovation, and at the same time strengthen technical research and equipment technical transformation, and strive to reduce production costs.
International Trading Company: clear positioning, strong management, cost control, market expansion
Conference requires international trading companies to further change their management concepts, take existing business operations as a starting point, and comprehensively improve their management level; On the basis of innovative business models, further introduce new varieties, new customers and expand new businesses; Make good use of the qualifications of non-car carriers to expand new business areas; strengthen standardized management, further optimize management processes, reduce management and operating costs, and improve profitability.
Cable Company: Flexible response to the market and strengthening internal management
Conference requires cable companies to adapt to the characteristics of small quantity, small size and high standard of the current cable market in view of the new situation inside and outside the enterprise, and adjust and establish a stable business model by establishing a broad and long-term stable customer base. Do a good job in fine, standardized management and process control to reduce production and operation costs; strengthen the flexibility of production organization, further strengthen quality control and staff skills training, reduce costs by reducing the failure rate and unnecessary loss, improve the profit space, and strive for greater benefits.
Peak Health: Plug Loopholes, Grasp Standards, and Strengthen Responsibility
In view of the current operating situation of Peak Health, the meeting required the management team to carefully analyze the current situation and market, grasp the key points, and guide the future production and operation work with new ideas and new thinking. To further strengthen the sense of responsibility of every post and every employee, establish an overall management and control system for procurement, production, inventory, and sales, and strengthen the control of the entire process of operation and management; carefully analyze the advantages of its own products and technologies, and strive to find a breakthrough in sales work, maximize profitable business, and strive to reverse the operation Dilemma. The
meeting pointed out that the new coronary pneumonia epidemic will have a significant impact on the market structure, business model, and development trends of many industries. The management teams of the company's subsidiaries should promptly grasp the market trends and develop with a long-term development perspective. Work, and strive to further improve the quality of work in the next three quarters, and complete the work goals set at the beginning of the year. (this newspaper reporter)
More information
Two Cement Enterprises Prosperous Production and Sales in May
With the gradual easing of the new crown epidemic, all over the project has started, Hubei, Yunnan two provinces cement market continued to improve, Daye peak cement company, Yunnan peak cement company two enterprises have recently shown a good momentum of production and sales. In May, the sales volume of Yunnan Jianfeng cement continued to rise. As of the time of publication, the average daily shipment volume reached more than 7400 tons, and the highest daily shipment volume reached more than 8700 tons, and the production capacity was fully released. Over the past few days, Yunnan Peak Packaging System has made great efforts to overcome the impact of narrow distribution sites and many cement varieties to ensure the completion of delivery tasks with good quality and quantity every day. In order to further balance production and sales and create conditions for the homogenization of cement delivered from the factory, Yunnan peak packaging system puts forward work requirements for relevant posts, emphasizes equipment inspection and process inspection during production, strictly implements safety operation procedures, and maintains safe and efficient operation of the system. Due to the impact of the new crown epidemic, Hubei cement market started late, Wuhan market is the hardest hit area, the current project construction is still not fully started, the volume pressure is greater. For this reason, daye peak departments cooperate closely, increase market development efforts, develop new mixing stations, focus on increasing the bulk share of Xianning, Huanggang and Wuhan markets, seize the opportunity of fine weather, and achieve the goal of rapid output. Internally, on the basis of equipment technical renovation and production capacity improvement, the delivery is effectively guaranteed, and the daily delivery capacity can basically be maintained at 10,000 tons. In May, Daye Peak sold more than 300000 tons of cement, an increase of 20% over the same period last year, with an average daily sales volume of more than 9900 tons, the highest in the current period since Daye Peak was put into production.
2020
07-31
The company's "safe production month" activities are about to start
June 2020 is the 19th national "safe production month", the theme of the activity is "eliminating hidden dangers of accidents and building a strong line of defense". A few days ago, the group company issued a notice to arrange the activities related to the organization of "safe production month" and put forward requirements. According to the group's "safe production month" activity plan, different key thematic activities will be held in the four weeks of June. The first week is the "Publicity and Safety Education Week", which focuses on the use of WeChat groups, electronic screens, publicity boards, banners, slogans and other forms for safety publicity, and organizes the study of national safety regulations, company safety system specifications and accident-free factory creation standards, Organize to watch safety warning education films, learn accident cases, etc., and improve employees' safety awareness by creating a safety atmosphere and organizing learning activities. The focus of the activities in the second week is "looking for potential sources of danger around you". Each unit takes departments and teams as units to investigate and analyze the potential risk factors in the process of daily production, maintenance and operation, find out the hazard sources that have not been included in the scope of risk point control, and report to the safety management department of the unit to form a risk assessment report, put forward solutions or suggestions, and supervise the implementation of rectification and timely eliminate potential safety hazards. The third week is the "on-site safety innovation achievements exhibition week", which focuses on the achievements of each unit in on-site safety management and on-site safety facilities in the past year, which are displayed in the form of pictures and texts through beautiful articles and wechat, so as to learn from each other and promote common progress. The fourth week is the "safety training and drill week", and the group company organizes the standardization of safety production and the elimination of hidden dangers.
2020
07-31
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-31
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-30
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-22
On April 24, Jiang Xiaomeng, chairman of the group company, presided over the 14th meeting of the 10th board of directors of the company, and deliberated and passed 14 related reports and motions such as the 2019 annual board of directors report, the 2019 general manager business report and the 2019 annual report. The general manager's report pointed out that 2019 is the first year of the implementation of the group's new five-year strategic development plan (2019-2023) and the new three-year business plan (2019-2021) for each business sector. the management team has carried out various operation and management work in an orderly manner around the general policy of "innovation and reform, integration and promotion, scientific layout and steady development", and has better completed the business objectives set by the board of directors at the beginning of the year. In the whole year, the company achieved a total operating income of 3.548 billion billion yuan, an increase of 5.51 percent over the same period last year; net profit attributable to shareholders was 0.725 billion billion yuan, with earnings per share reaching 2.11 billion yuan, an increase of 23.14 percent over the same period last year, a record high; total assets at the end of the year were 5.475 billion billion yuan, an increase of 11.71 percent over the same period last year; and net assets attributable to shareholders were 3.789 billion billion yuan, an increase of 19.81 percent. During the reporting period, the company's two main businesses have achieved great development, benefiting from the further promotion of supply-side structural reform, the overall operation of the cement industry in 2019 is stable, and the industry benefits are further improved. During the reporting period, the company made new progress in the construction of cement projects, completed the acquisition, capital increase and name change of Guizhou Mingchuan (Guizhou Huangping Jianfeng Cement Co., Ltd.), and continued to invest in the construction of its new dry cement production line with a daily output of 4500 tons of clinker.
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page